Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Simeprevir> ?p ?o. }
Showing items 1 to 48 of
48
with 100 items per page.
- Simeprevir abstract "Simeprevir (formerly TMC435; trade name Olysio) is a drug for the treatment and cure of hepatitis C. It was developed by Medivir and Johnson & Johnson's pharmaceutical division Janssen Pharmaceutica. In the United States, simeprevir is approved by the Food and Drug Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.".
- Simeprevir casNumber "923604-59-5".
- Simeprevir drugbank "DB06290".
- Simeprevir pubchem "56928193".
- Simeprevir thumbnail Simeprevir.svg?width=300.
- Simeprevir wikiPageID "37562094".
- Simeprevir wikiPageRevisionID "603788537".
- Simeprevir c "38".
- Simeprevir casNumber "923604".
- Simeprevir chemspiderid "23331536".
- Simeprevir drugName "Simeprevir".
- Simeprevir drugbank "DB06290".
- Simeprevir h "47".
- Simeprevir hasPhotoCollection Simeprevir.
- Simeprevir inchi "1".
- Simeprevir inchikey "JTZZSQYMACOLNN-VDWJNHBNBI".
- Simeprevir legalUs "Rx-only".
- Simeprevir molecularWeight "749.94".
- Simeprevir n "5".
- Simeprevir o "7".
- Simeprevir pubchem "56928193".
- Simeprevir s "2".
- Simeprevir smiles "Cc1cOC".
- Simeprevir stdinchi "1".
- Simeprevir stdinchikey "JTZZSQYMACOLNN-VDWJNHBNSA-N".
- Simeprevir synonyms "TMC435; TMC435350".
- Simeprevir tradename "Olysio".
- Simeprevir width "200".
- Simeprevir subject Category:Anti-RNA_virus_drugs.
- Simeprevir subject Category:Cyclopropanes.
- Simeprevir subject Category:Hepatitis_C.
- Simeprevir subject Category:Macrocycles.
- Simeprevir subject Category:Protease_inhibitors.
- Simeprevir subject Category:Quinolines.
- Simeprevir subject Category:Sulfonamides.
- Simeprevir subject Category:Thiazoles.
- Simeprevir type Drug.
- Simeprevir type FunctionalSubstance.
- Simeprevir comment "Simeprevir (formerly TMC435; trade name Olysio) is a drug for the treatment and cure of hepatitis C. It was developed by Medivir and Johnson & Johnson's pharmaceutical division Janssen Pharmaceutica. In the United States, simeprevir is approved by the Food and Drug Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.".
- Simeprevir label "Simeprevir".
- Simeprevir sameAs Siméprévir.
- Simeprevir sameAs m.0nd331d.
- Simeprevir sameAs Q7517689.
- Simeprevir sameAs Q7517689.
- Simeprevir wasDerivedFrom Simeprevir?oldid=603788537.
- Simeprevir depiction Simeprevir.svg.
- Simeprevir isPrimaryTopicOf Simeprevir.
- Simeprevir name "Simeprevir".
